Atlas Trials

Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD

Clinical trial NCT01689740 · COMPLETED

Trial details

NCT number
NCT01689740
Sponsor
Resilient Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Posttraumatic Stress Disorder (PTSD)
Start date
2013-01-17
Primary completion
2016-04-07
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.